J&J Ethicon launch of ThermaChoice uterine balloon backed by direct sales force of roughly 60 reps.
This article was originally published in The Gray Sheet
Executive Summary
ETHICON's LAUNCH OF THERMACHOICE UTERINE BALLOON THERAPY SYSTEM is being backed by a roughly 60-rep sales force specializing in women's health products. J&J began selling the device to U.S. gynecologists immediately following FDA approval Dec. 12.
You may also be interested in...
Gynecologists Likely To Have New Options For Treating Menorrhagia In 2001
BEI Medical Systems' Hydro ThermAblator (HTA) system for endometrial ablation will provide a new option for gynecologists in the treatment of menorrhagia when it becomes available, likely in early 2001.
Gynecologists Likely To Have New Options For Treating Menorrhagia In 2001
BEI Medical Systems' Hydro ThermAblator (HTA) system for endometrial ablation will provide a new option for gynecologists in the treatment of menorrhagia when it becomes available, likely in early 2001.
Ablation Versus Hysterectomy For Menorrhagia Achieves Cost Savings
Performing endometrial ablation in lieu of hysterectomy for treatment of dysfunctional uterine bleeding (DUB) can provide savings in the managed care setting, according to a recent study published in the American Journal of Managed Care.